2382719-60-8

2382719-60-8 structure
2382719-60-8 structure
  • Name: TT-OAD2
  • Chemical Name: TT-OAD2
  • CAS Number: 2382719-60-8
  • Molecular Formula: C50H49Cl4N3O6
  • Molecular Weight: 929.75
  • Catalog: Signaling Pathways GPCR/G Protein Glucagon Receptor
  • Create Date: 2020-06-02 02:04:05
  • Modify Date: 2025-08-25 11:46:07
  • TT-OAD2 is a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist with an EC50 of 5 nM. TT-OAD2 has the potential for diabetes treatment[1][2].

Name TT-OAD2
Description TT-OAD2 is a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist with an EC50 of 5 nM. TT-OAD2 has the potential for diabetes treatment[1][2].
Related Catalog
Target

EC50: 5 nM (GLP-1 receptor)[2]

In Vitro TT-OAD2 (0-10 μM) inhibits GLP-1- and oxyntomodulin-mediated cAMP, calcium, pERK1/2 and β-arrestin responses in a concentration-dependent manner in HEK293A cells[1].
In Vivo TT-OAD2 (3 mg/kg; intravenous injection; male human GLP-1 receptor knock-in and knockout mice) treatment induces plasma insulin in an acute IVGTT on humanized GLP-1R knock-in (KI) and GLP-1R knockout (KO) mice[1]. Animal Model: Male human GLP-1 receptor knock-in and knockout mice (6-11 months of age) with intravenous glucose tolerance tests[1] Dosage: 3 mg/kg Administration: Intravenous injection (Single dose) Result: Induced plasma insulin.
References

[1]. Zhao P, et al. Activation of the GLP-1 receptor by a non-peptidic agonist. Nature. 2020 Jan;577(7790):432-436.

[2]. Transtech Pharma, et al. Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof. WO2010114824A1.

Molecular Formula C50H49Cl4N3O6
Molecular Weight 929.75
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.